Phlexglobal has announced the acquisition of UK-based Net Solutions Europe (NSE), an established technology company with a proven track record in delivering superior software solutions.
Phlexglobal has been working in partnership with NSE since 2010 on the development of PhlexEview, its market leading electronic TMF (eTMF) cloud based platform.
The acquisition fortifies its position at the forefront of the provision of eTMF solutions and technology enabled services.
Phlexglobal chief technology officer Peter McNaney said: "As Phlexglobal’s technology partner, NSE has demonstrated a regulatory understanding of the sensitivity of the clinical documents we handle, and their expertise and experience is second to none.
"We also have appointed an expert eTMF product manager working as part of the newly expanded technology team, and this appointment coupled with the NSE acquisition will further ensure we are at the leading edge of eTMF technology capabilities."
CEO Rick Riegel said: "This acquisition allows us to fast-track the future development of PhlexEview, our cloud based eTMF platform.
"The resulting enhanced capabilities will provide significant additional benefits to both our software and our services clients."
Phlexglobal is committed to developing technology solutions for the TMF market to expedite study start-up, facilitate regulatory inspection readiness, and improve management and oversight.
The technology of choice for more than 30 global companies, which includes the top ten pharmaceutical companies, biotechs and CROs with thousands of worldwide users, a major new release of PhlexEview is anticipated later this year.